ArticleTranslational cancer research2014
A recursively partitioned mixture model for clustering time-course gene expression data.
Article in Translational cancer research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Article
- Exploring the longitudinal dynamics of herd BVD antibody test results using model-based clustering.Scientific reports · 2019Article
- Promoter methylation of DNA damage repair (DDR) genes in human tumor entities:Clinical epigenetics · 2018Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundLongitudinally collected gene expression data provides an opportunity to investigate the dynamic behavior of gene expression and is crucial for establishing causal links between changes on a molecular level and disease development and progression. In terms of the analysis of such data, clustering of subjects based on time-course expression data may improve our understanding of temporal expression patterns that result in disease phenotypes. Although there are numerous existing methods for clustering subjects using gene expression data, most are not suitable when expression measurements are repeatedly collected over a time-course.
methodsWe present a modified version of the recursively partitioned mixture model (RPMM) for clustering subjects based on longitudinally collected gene expression data. In the proposed time-course RPMM (TC-RPMM), subjects are clustered on the basis of their temporal profiles of gene expression using a mixture of mixed effects models framework. This framework captures changes in gene expression over time and models the autocorrelation between repeated gene expression measurements for the same subject. We assessed the performance of TC-RPMM using extensive simulation studies and a dataset from a multi-center research study of inflammation and response to injury (www.gluegrant.org), which consisted of time-course gene expression data for 140 subjects.
resultsOur simulation studies encompassed several different scenarios and were aimed at assessing the ability of TC-RPMM to correctly recover true class memberships when the expression trajectories that characterized those classes differed. Overall, our simulation studies revealed favorable performance of TC-RPMM compared to competing approaches, however clustering performance was observed to be highly dependent on the proportion of class discriminating genes used in clustering analysis. When applied to real epidemiologic data with repeated-measures, longitudinal gene expression measurements, TC-RPMM identified clusters that had strong biological and clinical significance.
conclusionsMethods for clustering subjects based on temporal gene expression profiles is a high priority for molecular biology and bioinformatics research. Along these lines, the proposed TC-RPMM represents a promising new approach for analyzing time-course gene expression data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.